ENDONOVO THERAPEUTICS, INC.
ENDV · OTCMCIK 1528172fmd_1EWE4A38EC53VA28HRKN0E5Z55Manufacturing · Electromedical & Electrotherapeutic ApparatusTemplate: Standard
Coverage: Jan 01, 2010 to Sep 30, 2023, 50 periods
| Line item | FY2013 | FY2014 | FY2015 | FY2016 | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenues | 0 | 0 | 0 | – | – | 0 | 0 | 0 | 0 | 0 |
| Net interest income | (0) | (0) | (2) | (2) | (6) | (5) | (6) | (2) | (1) | (1) |
| Cost of revenue | 0 | 0 | 0 | – | – | 0 | 0 | 0 | 0 | 0 |
| Gross profit | 0 | 0 | 0 | – | – | 0 | 0 | 0 | 0 | 0 |
| Research and development | – | – | – | 0 | 0 | 0 | 0 | 0 | 0 | – |
| Total operating expenses | 2 | 2 | 3 | 5 | 5 | 4 | 4 | 3 | 2 | 3 |
| Operating income | (2) | (2) | (3) | (5) | (5) | (4) | (4) | (3) | (2) | (3) |
| Interest expense | – | – | – | – | – | – | 0 | 2 | 1 | – |
| Other non-operating income (expense) | – | 1 | (4) | 0 | (6) | (2) | (14) | 3 | (1) | (15) |
| Income before taxes | (3) | (1) | (7) | (5) | (11) | (6) | (17) | (0) | (3) | (18) |
| Income tax expense | 0 | 0 | 0 | – | – | – | – | – | – | – |
| Net income from continuing operations | (3) | (1) | (7) | – | – | – | – | – | – | – |
| Net income | (3) | (1) | (7) | (5) | (11) | (6) | (17) | (0) | (3) | (18) |